Quebec biopharmaceutical company sees encouraging early COVID-19 vaccine tests

Must Read

Northern Health sees one new case of COVID-19, nine new cases across BC as of Wednesday

VICTORIA, B.C. – The total number of confirmed COVID-19 cases in the Northern Health Region is now at 63...

New dock installed at Gwillim Lake Provincial Park

TUMBLER RIDGE, B.C. - To provide better lake access for boaters, a new dock has been installed at Gwillim...

National Tourism Week festivities taking place this week in Dawson Creek

DAWSON CREEK, B.C. - Even with the COVID-19 pandemic going on, Tourism Dawson Creek is encouraging residents to celebrate...

By Staff The Canadian Press

Posted May 14, 2020 9:46 pm

Updated May 14, 2020 10:14 pm

- Advertisement -

Community Interviews with Moose FM


0:56Coronavirus: 72% of Canadians support mandatory vaccine, Ipsos poll suggests

More than two-thirds of Canadians support the idea that a vaccine for COVID-19, the disease caused by the novel coronavirus, should be mandatory for all once it’s developed and available for distribution, a new poll by Ipsos suggests.

Quebec biopharmaceutical company Medicago said on Thursday it was getting encouraging early results from its COVID-19 vaccine testing.

The company said its product has generated a positive antibody response in mice ten days after the administration of a single dose.

These results are a first step before Medicago can conduct clinical studies in people.

2:04COVID-19 treatments explained

Advertisement

Advertisement


COVID-19 treatments explained

Once the results of a second “booster” dose are obtained, Medicago said it will submit a clinical trial request to Health Canada as well as a new drug request to the United States Food and Drug Administration to allow the start of clinical trials on humans.

 » READ MORE FROM GLOBAL NEWS

More Articles Like This